Molecular and clinicopathologic features of gliomas harboring NTRK fusions | Acta Neuropathologica Communications | Full Text

Molecular and clinicopathologic features of gliomas harboring NTRK fusions | Acta Neuropathologica Communications | Full Text

Molecular and clinicopathologic features of gliomas harboring NTRK fusions

Fusions involving neurotrophic tyrosine receptor kinase (NTRK) genes are detected in ≤2% of gliomas and can promote gliomagenesis. The remarkable therapeutic efficacy of TRK inhibitors, which are among the first ...

Authors:Matthew Torre, Varshini Vasudevaraja, Jonathan Serrano, Michael DeLorenzo, Seth Malinowski, Anne-Florence Blandin, Melanie Pages, Azra H. Ligon, Fei Dong, David M. Meredith, MacLean P. Nasrallah, Craig Horbinski, Sonika Dahiya, Keith L. Ligon, Mariarita Santi, Shakti H. Ramkissoon…

Citation:Acta Neuropathologica Communications 2020 8:107

Content type:Research

 

Published on: 14 July 2020

• ViewFull Text
 
• ViewPDF